Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS. (Q53056378)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

1 reference

based on heuristic

inferred from title

hemodialysis patient

1 reference

based on heuristic

inferred from title

9

object named as

Friedrich K Port

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

5

object named as

Takashi Akiba

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Bruce M. Robinson

8

object named as

Bruce M Robinson

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Jennifer Bragg-Gresham

2

object named as

Jennifer L Bragg-Gresham

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

6

object named as

Akira Saito

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

author name string

Antonio Alberto Lopes

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Sylvia P B Ramirez

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Vittorio E Andreucci

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Stefan H Jacobson

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Nancy A Mason

10

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Eric W Young

11

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

language of work or name

0 references

publication date

14 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

24

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

9

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

2809-2816

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Associations of kidney function with cardiovascular medication use after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Econometrics in outcomes research: the use of instrumental variables

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Losartan and end-organ protection--lessons from the RENAAL study.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Interdialytic weight gain: implications in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Identifiers

10.1093/NDT/GFP212

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53056378&oldid=2255069235"